Gene · 51115
Papers3,244
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,244
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Aberrant expression of SPAG6 may affect the disease phenotype and serve as a tumor biomarker in BCR/ABL1-negative myeloproliferative neoplasms. | Oncol Lett | 2022 | 34820009 | PubTator, text mining | PubMed |
| Alzheimer's disease and progressive supranuclear palsy share similar transcriptomic changes in distinct brain regions. | J Clin Invest | 2022 | 34813500 | PubTator, text mining | PubMed |
| Cognitive impairment and World Trade Centre-related exposures. | Nat Rev Neurol | 2022 | 34795448 | PubTator, text mining | PubMed |
| Amygdala DCX and blood Cdk14 are implicated as cross-species indicators of individual differences in fear, extinction, and resilience to trauma exposure. | Mol Psychiatry | 2022 | 34728797 | PubTator, text mining | PubMed |
| Distinct DNA Methylation Patterns of Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex. | Cell Mol Neurobiol | 2022 | 34709498 | PubTator, text mining | PubMed |
| Extracellular vesicles: Major actors of heterogeneity in tau spreading among human tauopathies. | Mol Ther | 2022 | 34563677 | PubTator, text mining | PubMed |
| Application value of biofluid-based biomarkers for the diagnosis and treatment of spinal cord injury. | Neural Regen Res | 2022 | 34558509 | PubTator, text mining | PubMed |
| Association of CD2AP neuronal deposits with Braak neurofibrillary stage in Alzheimer's disease. | Brain Pathol | 2022 | 34514662 | PubTator, text mining | PubMed |
| Alzheimer's Disease and other Tauopathies: Exploring Efficacy of Medicinal Plant-derived Compounds in Alleviating Tau-mediated Neurodegeneration. | Curr Mol Pharmacol | 2022 | 34488602 | PubTator, text mining | PubMed |
| Extracranial carotid atherosclerosis is associated with increased neurofibrillary tangle accumulation. | J Vasc Surg | 2022 | 34478810 | PubTator, text mining | PubMed |
| PLGA-Based Curcumin Delivery System: An Interesting Therapeutic Approach in the Treatment of Alzheimer's Disease. | Curr Neuropharmacol | 2022 | 34429054 | PubTator, text mining | PubMed |
| Pathological mechanisms and therapeutic strategies for Alzheimer's disease. | Neural Regen Res | 2022 | 34380884 | PubTator, text mining | PubMed |
| Traumatic Brain Injury and Risk of Neurodegenerative Disorder. | Biol Psychiatry | 2022 | 34364650 | PubTator, text mining | PubMed |
| Investigation of the peripheral inflammation (neutrophil-lymphocyte ratio) in two neurodegenerative diseases of the central nervous system. | Neurol Sci | 2022 | 34331157 | PubTator, text mining | PubMed |
| Emerging small-molecule therapeutic approaches for Alzheimer's disease and Parkinson's disease based on targeting microRNAs. | Neural Regen Res | 2022 | 34269206 | PubTator, text mining | PubMed |
| Stem cell-based 3D brain organoids for mimicking, investigating, and challenging Alzheimer's diseases. | Neural Regen Res | 2022 | 34269204 | PubTator, text mining | PubMed |
| Exosomal and vesicle-free tau seeds-propagation and convergence in endolysosomal permeabilization. | FEBS J | 2022 | 34092031 | PubTator, text mining | PubMed |
| The propagation mechanisms of extracellular tau in Alzheimer's disease. | J Neurol | 2022 | 33913022 | PubTator, text mining | PubMed |
| SH-SY5Y-derived neurons: a human neuronal model system for investigating TAU sorting and neuronal subtype-specific TAU vulnerability. | Rev Neurosci | 2022 | 33866701 | PubTator, text mining | PubMed |
| Prediction of Outcome After Endovascular Embolectomy in Anterior Circulation Stroke Using Biomarkers. | Transl Stroke Res | 2022 | 33723754 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51115/papers?page=36